- $1.47bn
- $1.33bn
- $188.76m
- 37
- 48
- 50
- 42
Annual income statement for IREN, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
R2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.17 | 7.9 | 59 | 75.5 | 189 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.85 | 8.42 | 58.7 | 232 | 215 |
| Operating Profit | -1.68 | -0.524 | 0.295 | -157 | -26.3 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.14 | -59.2 | -417 | -169 | -25.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.14 | -60.4 | -420 | -172 | -29 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.14 | -60.4 | -420 | -172 | -29 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.14 | -60.4 | -420 | -172 | -29 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.039 | -1.09 | -10.2 | -1.84 | -0.276 |
| Dividends per Share |